Introduction {#s1}
============

Stent-assisted coil embolization (SACE) is a popular treatment strategy for wide-necked intracranial aneurysms (IAs) and is associated with a higher occlusion rate and lower recurrence rate ([@B1]--[@B5]). From laser cut stents (e. g., Enterprise stent) to braided stents (e. g., LVIS) and now the flow diverter (e. g., Pipeline embolization device), the design and concept of stents used for the treatment of IAs are continuously developing. The efficacy of endovascular treatment with these devices was also reported to increase with their development. For example, the occlusion rate of IAs treated by flow diverter is \>90% ([@B6]). However, the indication of the flow diverter is strict, and it is commonly used in large or giant aneurysms. In recent years, a novel, self-expandable braided stent (LVIS) has become widely used, which has a smaller cell structure and a higher metal coverage than the Enterprise stent ([@B7]--[@B9]). The angiographic outcome of IAs treated with LVIS was reported to be favorable ([@B9]--[@B13]). For example, in a previous study from our center, the recanalization rate of aneurysms with an LVIS stent was lower than aneurysms treated with the Enterprise stent, while the rate of progressive thrombosis occlusion was significantly higher in the LVIS group ([@B10]). However, the underlying mechanisms of action remain controversial.

Hemodynamic alterations induced by stents were reported to be involved in aneurysm outcomes. Computational fluid dynamics (CFD) is a valuable tool for evaluating the hemodynamic effects of aneurysm recurrence ([@B14]--[@B16]). However, the hemodynamic effects of LVIS in aneurysm outcomes remain unknown, and to our knowledge, there are no reported hemodynamic comparison studies based on a series of clinical cases. Thus, in the present study, we retrospectively collected data from patients with IAs who were treated with LVIS and Enterprise stents in our center. For large or giant aneurysms, the flow diverter was reported to be a better treatment method ([@B17], [@B18]). However, in those studies, the indication of the flow diverter was strict, and complex aneurysm (large, giant, and fusiform aneurysms) was the main indication. For medium-sized IAs (≥7, ≤ 12 mm) ([@B19]), the traditional stent-assisted technique may be more appropriate for its low metal coverage and dense packing. By contrast, the Enterprise and LVIS stents are the two most commonly used intracranial stents that have different structure designs. We hypothesized that differences in the hemodynamic effects of these stents may underlie the different outcomes of aneurysms treated with these two devices.

Materials and Methods {#s2}
=====================

Patient Selection
-----------------

The study was approved by the ethics committee of Beijing Tiantan hospital. Consent was obtained from the patients or their closest relatives before the study. We retrospectively reviewed the medical records and image data in our aneurysm database. A series of patients were reviewed and collected from February 2016 to January 2017. Patients were screened retrospectively based on the following inclusion criteria: (1) diagnosis of medium-sized aneurysms by angiography (size range from 7 to 12 mm) and treated with LVIS (MicroVention, Tustin, CA, USA) or Enterprise SACE (Cordis Neurovascular, Miami, FL, USA), (2) available follow-up angiography performed to determine whether the aneurysm had recanalized, and (3) sufficient resolution of three-dimensional (3D) digital subtraction angiography images for CFD simulation. Two experienced neurointerventionalists (5 years of experience in endovascular treatment) who were independent of the study evaluated the angiography results and radiographic images, and disagreements were resolved by a third neurointerventionalist (10 years of experience in endovascular treatment). According to the Raymond--Roy classification system ([@B20]), the angiographic results of aneurysm embolization were quantified (class 1, complete obliteration; class 2, a residual neck; class 3, a residual aneurysm). Recanalization was defined as any further contrast filling of the aneurysm sac observed on follow-up angiography compared with the initial treatment results ([@B14]). Aneurysms treated with the LVIS stent were allocated to the LVIS group, while aneurysms treated with the Enterprise stent were allocated to the Enterprise group. For all included cases, clinical data \[age, sex, hypertension, cigarette smoking, multiple aneurysm, aneurysm location, packing density (PD), follow-up interval, complication rates, and retreatment rates\], and morphological data (aneurysm size, neck size, and aspect ratio) were collected from medical records and imaging studies.

Computational Modeling, Hemodynamic Simulations, and Hemodynamic Analysis
-------------------------------------------------------------------------

Patient-specific 3D-digital subtraction angiography data of all aneurysms were obtained before treatment. Using Geomagic Studio version 12.0 software (Geomagic, Research Triangle Park, NC, USA), the 3D geometry surface was displayed, segmented, and smoothed. The geometries were saved in standard tessellation language format. A novel virtual stenting technique ([@B21], [@B22]) and porous media method ([@B23]) were used to simulate the *in vivo* stent and coil mass in the aneurysm dome region. The virtual stenting workflow was as follows: (1) preprocessing: isolated the parent vessel from the aneurysm and trimmed down the stent deployment region; (2) simplex mesh expansion: the centerline was obtained within the parent vessel to undergo radial expansion to initialize a simplex mesh, and the expansion was stopped when the initialized simplex mesh had good apposition with the parent--vessel wall; (3) post-processing: the LVIS and Enterprise stent pattern was mapped to the simplex mesh, and the wires were swept into the 3D structures using CAD software (Creo Parametric 2.0; PTC Needham, MA, USA) ([@B22]). The aneurysmal sac with coils was modeled as a porous medium as described by Mitsos et al. ([@B23]). The virtual stent was merged with the aneurysm geometry using ICEM CFD software (ANSYS, Inc., Canonsburg, PA, USA) to create \>1,000,000 finite-volume tetrahedral elements. The maximum element size and the element size on stents were set at 0.2 mm and one-third of the width of the strut of these stents approximately. ANSYS CFX 14.0 software (ANSYS, Inc.,) was used to simulate the hemodynamics of the aneurysm after meshing. We treated blood as a Newtonian fluid. The blood vessel wall was assumed to be rigid with no-slip boundary conditions. The density was specified as ρ = 1,060 kg/m^3^, and the dynamic viscosity of blood was μ = 0.004 Pa·s. The governing equations underlie the calculation based on the Navier--Stokes formula, with the assumption of homogeneous, laminar, incompressible blood flow. The inflow boundary condition was obtained using transcranial Doppler imaging as a representative pulsatile period velocity profile. The outlet pressure conditions at outlet arteries in our study were imposed to p = 0 Pa. The flow waveforms were scaled to achieve a mean inlet wall shear stress (WSS) of 15 dynes/cm under pulsatile conditions ([@B22]). To confirm the stability, we selected the third cardiac cycle of three cardiac cycle simulations as output for the final analyses.

We then post-processed and visualized the results of these simulations using the ANSYS CFD-Post. The hemodynamic results at peak systole were carefully examined. In our clinical practice, the jailing technique was used in the present cases. We first deployed a stent to jail the microcatheter and then performed coil embolization. Thus, we created a group of three models (before treatment, after stent deployment, and after SACE), compared the flow alterations during the entire procedure between the three models, and estimated the hemodynamic effects of stenting and coiling. All results were collected before stent placement, after stent placement, and after SACE. The hemodynamic parameters were collected at systolic peak. The average flow velocity at the aneurysm neck plane was calculated, and the aneurysm neck plane was created at the location where the aneurysm sac pouched outward from the parent artery. Moreover, the average flow velocity inside the aneurysm and the average WSS on the whole aneurysm wall were also calculated. We defined the reduction ratios of the parameter as (pretreatment parameter---post-treatment parameter)/pretreatment parameter. For hemodynamic parameters, the reduction ratios of the flow velocity at the aneurysm neck plane, the flow velocity in the aneurysm, and WSS on the aneurysm were analyzed. Hemodynamic alterations by stent deployment were defined as the reduction ratios between before and after stent placement, hemodynamic alterations by coil embolization were the reduction ratios between after stent placement and after SACE, and total hemodynamic alterations were the reduction ratios between before and after SACE.

Statistical Analysis
--------------------

For qualitative data, the χ2 test or the Fisher\'s exact test was used to compare the differences between the LVIS and Enterprise groups. For quantitative data, the Mann--Whitney *U*-test was used to compare between the two groups. The factors with a *P* \< 0.2 in univariate analysis were entered into a multivariate logistic regression analysis to assess the independent factors related to treatment. The OR with 95% CIs was calculated between the LVIS and Enterprise group. Statistical analyses were performed using statistical software (SPSS version 21.0; SPSS Inc., Chicago, IL, USA). The level of statistical significance was established at *P* \< 0.05.

Results {#s3}
=======

After review, 87 patients with 87 medium-sized IAs were treated with LVIS SACE or Enterprise SACE in our study. Forty-two aneurysms were treated with LVIS and 45 with the Enterprise stent. One aneurysm was recanalized in the LVIS group, while five aneurysms were recanalized in the Enterprise group. Aneurysms in the LVIS group showed a lower recanalization rate (2.4 vs. 11.1%, respectively; *P* = 0.108; [Table 1](#T1){ref-type="table"}).

###### 

Patient demographics and aneurysm morphology in patients with Enterprise stent-assisted coil embolization (SACE) and LVIS SACE.

                                          **Enterprise group (*n* = 45)**   **LVIS group (*n* = 42)**   ***P*-value**
  --------------------------------------- --------------------------------- --------------------------- ---------------
  Age, y                                  55.38 ± 9.61                      53.60 ± 8.55                0.417
  Female sex, *n* (%)                     35 (77.8)                         30 (71.4)                   0.496
  Hypertension (HTN), *n* (%)             12 (22.7)                         8 (19.0)                    0.675
  Cigarette smoking, *n* (%)              6 (13.3)                          5 (11.9)                    0.841
  Drinking, *n* (%)                       5 (11.1)                          3 (7.1)                     0.522
  Ruptured aneurysms, *n* (%)             9 (20.0)                          5 (11.9)                    0.305
  Multiple aneurysms, *n* (%)             11 (24.4)                         7 (16.7)                    0.371
  Anterior circulation, *n* (%)           42 (93.3)                         39 (92.9)                   0.930
  Aneurysm size, mm                       8.95 ± 1.82                       8.81 ± 1.89                 0.718
  Aneurysm neck, mm                       6.25 ± 1.78                       5.87 ± 1.40                 0.273
  Aspect ratio (AR)                       1.50 ± 0.38                       1.54 ± 0.29                 0.579
  Packing density (%)                     25.58 ± 6.44                      28.34 ± 7.01                0.146
  Initial angiographic result                                                                           0.069
  Complete obliteration                   20 (44.4)                         29 (69.0)                   
  Residual neck                           21 (46.7)                         11 (26.2)                   
  Residual aneurysm                       4 (8.9)                           2 (4.8)                     
  Follow-up interval, mo                  11.82 ± 9.26                      9.10 ± 4.01                 0.932
  Thromboembolic complications, *n* (%)   4 (8.9)                           5 (11.9)                    0.644
  Hemorrhagic complications, *n* (%)      1 (2.2)                           1 (2.4)                     0.961
  Recanalization, *n* (%)                 5 (11.1)                          1 (2.4)                     0.108
  Retreatment, *n* (%)                    3 (6.7)                           1 (2.4)                     0.340

*Continuous variables are expressed as mean ± standard deviation. Categorical variables are expressed as n (%)*.

Clinical and Morphological Factors
----------------------------------

Patient demographics and aneurysm morphology of the LVIS and Enterprise groups are shown in [Table 1](#T1){ref-type="table"}. There were no significant differences in any factors between the two groups. However, patients tended to be younger with less women in the LVIS group. The mean maximum size and neck of the aneurysm in the Enterprise group was also slightly larger than that in the LVIS group, while the AR was slightly smaller. There was a trend toward a higher complete obliteration rate in the LVIS group compared with the Enterprise group (69.0 vs. 44.4%, respectively; *P* = 0.069). The PD of aneurysms in the LVIS group was higher (28.34 ± 7.01 vs. 25.58 ± 6.44%, respectively). Further, the follow-up interval time was longer in the Enterprise group. There were no significant differences in the rate of complications between the two groups: thromboembolic complications occurred in five patients (11.9%) in the LVIS group and in four patients (8.9%) in the Enterprise group (*P* = 0.644). Regarding hemorrhagic complications, intraoperative rupture occurred in one patient in the LVIS group and in one patient in the Enterprise group (*P* = 0.961). The retreatment rate also showed no significant differences between the two groups (*P* = 0.340).

Hemodynamic Alterations by Staged SACE
--------------------------------------

The alterations of hemodynamic parameters between the LVIS and Enterprise group by staged SACE are shown in [Table 2](#T2){ref-type="table"}.

###### 

Univariate analysis results for hemodynamic parameters between the two groups.

  **Parameters**                   **Enterprise group (*n* = 45), Reduction rate (%)**   **LVIS group (*n* = 42), Reduction rate (%)**   ***P*-value**
  -------------------------------- ----------------------------------------------------- ----------------------------------------------- ---------------
  **VELOCITY ON THE NECK PLANE**                                                                                                         
  Stent                            26.70 ± 15.71                                         44.74 ± 18.14                                   \< 0.001
  Coil                             13.91 ± 32.29                                         26.20 ± 31.38                                   0.185
  Total                            39.81 ± 17.76                                         59.52 ± 23.63                                   \< 0.001
  **VELOCITY ON THE ANEURYSM**                                                                                                           
  Stent                            22.59 ± 12.95                                         28.65 ± 14.84                                   0.021
  Coil                             61.18 ± 20.19                                         83.78 ± 17.66                                   \< 0.001
  Total                            69.45 ± 17.78                                         88.46 ± 13.30                                   \< 0.001
  **WSS ON THE ANEURYSM**                                                                                                                
  Stent                            20.15 ± 12.26                                         23.33 ± 13.95                                   0.281
  Coil                             60.40 ± 20.36                                         81.54 ± 21.40                                   \< 0.001
  Total                            69.49 ± 15.01                                         85.45 ± 18.12                                   \< 0.001

*The Mann--Whitney u test was used, with P \< 0.05 considered statistically significant. WSS, wall shear stress; Stent, hemodynamic alterations by stent deployment; Coil, hemodynamic alterations by coil placement; Total, total hemodynamic alterations after SACE*.

Hemodynamic Alterations by Stent Deployment
-------------------------------------------

For alterations in hemodynamic parameters by stent deployment, the hemodynamic parameters in both groups showed a greater reduction ratio for the velocity at the neck plane compared with the velocity and WSS of the aneurysm. However, in the LVIS group, the reduction ratio for the velocity at the neck plane (44.74 ± 18.14 vs. 26.70 ± 15.71, respectively; *P* \< 0.001) and velocity of the aneurysm (28.65 ± 14.84 vs. 22.59 ± 12.95, respectively; *P* = 0.021) was significantly different than for the Enterprise group. The reduction of WSS on the aneurysm was also higher but showed no significance (*P* = 0.281).

Hemodynamic Alterations by Coil Embolization
--------------------------------------------

For the alterations of hemodynamic parameters by coil embolization after stent deployment, there were further reductions in the velocity at the neck plane, velocity in the aneurysm, and WSS on the aneurysm after coil placement. However, the velocity in the aneurysm and WSS on the aneurysm showed a greater reduction ratio compared with the velocity at the neck plane for both groups. Moreover, the velocity in the aneurysm (83.78 ± 17.66 vs. 61.18 ± 20.19, respectively; *P* \< 0.001) and WSS at the aneurysm (28.65 ± 14.84 vs. 22.59 ± 12.95, respectively; *P* = 0.021) were significantly lower in the LVIS group compared with the Enterprise group, while there was no difference in velocity at the neck plane.

Total Hemodynamic Alterations by SACE
-------------------------------------

For total hemodynamic alterations after SACE, there was a greater reduction ratio in the LVIS group for the various hemodynamic parameters ([Table 2](#T2){ref-type="table"}). Compared with the Enterprise group, cases with LVIS SACE showed a greater reduction in velocity at the neck plane (59.52 vs. 39.81%, respectively; *P* \< 0.001), aneurysmal velocity (88.46 vs. 69.45%, respectively; *P* \< 0.001), and WSS on the aneurysm (85.45 vs. 69.49%, respectively; *P* \< 0.001). An unrecanalized example showed that blood flow in the aneurysms was remodeled and that the hemodynamics in aneurysm neck and aneurysm were obviously decreased after LVIS SACE ([Figure 1](#F1){ref-type="fig"}). However, in the Enterprise group, the average velocity at the neck plane, velocity in the aneurysm, and WSS on the aneurysm decreased by 39.81, 69.45, and 69.49%, respectively, after treatment. A recanalized case with Enterprise SACE showed that the WSS and velocity of the aneurysm were decreased, while the velocity on the neck remained higher ([Figure 2](#F2){ref-type="fig"}). Of all the significant factors in univariate analysis, only the reduction ratio of the velocity at the neck plane correlated significantly with treatment of different stent in multivariate logistic regression analysis ([Table 3](#T3){ref-type="table"}).

![Digital subtraction angiography (DSA) showing a stable aneurysm (8.9 × 7.2 mm) with LVIS stent-assisted coil embolization (SACE) (A1, A2, A3, arrows). Compared with the preprocedural angiographic image (A1), the aneurysm showed residual flow in the post-procedural immediate angiographic image (A2, arrow). At 6 months of follow-up, DSA indicated that the aneurysm was stable (A3, arrow). In hemodynamic simulation, compared with preprocedural results (B1, C1, D1, E1), the velocity streamline was decreased (B2, arrow), the velocity in the aneurysm and wall shear stress (WSS) was decreased (C2 and D2, arrows), and the velocity of the aneurysm neck plane was markedly reduced (E2, arrow) after stent deployment. After coil placement, the streamline in the aneurysm and the velocity and WSS of aneurysm were further decreased (B3, C3, and D3), but with limited changes in velocity at the neck plane (E3).](fneur-10-00522-g0001){#F1}

![DSA showing a recanalized aneurysm (9.7 × 9.8 mm) with Enterprise SACE (A1, A2, A3, arrows). In post-procedural immediate angiographic images, the aneurysm showed a residual neck (A2, arrow). At 6 months of follow-up, DSA indicated that the aneurysm was recanalized (A3, arrow). In hemodynamic simulation, compared with preprocedural results (B1, C1, D1, E1), there were no marked changes in blood flow in the aneurysm after stent deployment (B2, C2, arrows). Further, there were limited changes in WSS on the aneurysm and velocity at the neck plane after stent deployment (D2, E2, arrows). With further coil placement (B3, C3, D3, E3), the velocity and WSS of the aneurysm had decreased. However, the blood flow velocity near the aneurysmal neck remained concentrated (B3, C3, arrows), the wall shear stress of the region near the aneurysmal neck remained high (D3, Arrows), and the impingement region at the remnant neck was consistent with the region where the recanalization occurred at follow-up (A3, E3, arrows).](fneur-10-00522-g0002){#F2}

###### 

Multivariate analysis between LVIS and Enterprise groups.

  **Variables**                        **OR\# (95% CI)**     ***P*-value**
  ------------------------------------ --------------------- ---------------
  Packing density                      0.02 (0.00--760.22)   0.343
  Initial angiographic result          0.19 (0.01--5.01)     0.320
  Recanalization                       0.12 (0.01--14.80)    0.386
  Velocity on the neck plane (Stent)   0.80 (0.67--0.96)     0.014
  Velocity on the neck plane (Coil)    0.88 (0.77--1.00)     0.054
  Velocity on the neck plane (Total)   1.17 (0.96--1.43)     0.130
  Velocity on the aneurysm (Stent)     1.02 (0.93--1.11)     0.704
  Velocity on the aneurysm (Coil)      0.98 (0.73--1.30)     0.872
  Velocity on the aneurysm (Total)     0.95 (0.65--1.38)     0.792
  WSS on the aneurysm (Coil)           0.86 (0.73--1.01)     0.064
  WSS on the aneurysm (Total)          1.17 (0.96--1.42)     0.120

*WSS, wall shear stress; Stent, hemodynamic alterations by stent deployment; Coil, hemodynamic alterations by coil placement; Total, total hemodynamic alterations after SACE*.

Discussion {#s4}
==========

We performed a comparison study of LVIS and Enterprise SACE based on a series of clinical cases. The aneurysms with LVIS SACE showed a lower recanalization rate than those with Enterprise SACE. The velocity at the neck plane also showed a greater reduction after stent deployment compared with after coil placement, while the reduction ratio of the aneurysmal velocity and WSS was higher after coil placement. These findings suggest that coils mainly decrease the hemodynamics of the aneurysm dome, while stents mainly affect the velocity at the aneurysmal neck. Thus, the greater hemodynamic changes at the aneurysm neck and dome caused by the LVIS stent and high dense coils may play an important role in preventing aneurysm recanalization. In addition, the reduction ratio of the velocity at the neck plane was a significant independent factor between LVIS and Enterprise groups.

Flow Remodeling Effect of Stents for Preventing Aneurysm Recanalization
-----------------------------------------------------------------------

SACE was developed from the concept that scaffolding in the parent artery of wide-necked aneurysms would prevent coil herniation (by stabilizing the coil) and aneurysm recurrence. Stent placement can also cause progressive endothelialization and reconstruction of the parent vessel. Moreover, an advantage of SACE is its potential for floreremodeling effects, with numerous studies showing that stents produce flroducesngtion effects to decrease the hemodynamics of the aneurysm ([@B24]--[@B26]). It is also well-established that flha diverters produce stronger fltrongersedson effects than for the Enterprise stent, with further hemodynamic reductions in the aneurysm ([@B24]--[@B26]). However, these studies mainly examined the hemodynamics of the Enterprise stent and flow-diverter device, while there is limited information on the effects of the LVIS stent on aneurysm hemodynamics. Nevertheless, in one study, the LVIS stent was reported to produce hemodynamic effects on cerebral aneurysms, with a single LVIS stent producing greater flow reductions than the two Enterprise stents, but less than for the Pipeline device ([@B22]). However, the findings in that study were not compared with clinical outcomes. In the present study, we selected two consecutive clinical cases to compare the hemodynamic alterations of aneurysms after SACE between patients treated with LVIS or the Enterprise stent. We found that greater reductions in velocity at the neck plane and in the aneurysm after LVIS stent deployment, and the reductions in velocity at the neck plane were the independent factors between the two groups. It was previously reported that a reduction in flow velocity at the neck plane was the most important factor for preventing aneurysm recanalization ([@B27], [@B28]). We found that the hemodynamic alterations in the LVIS group (including a significant reduction in velocity at the neck plane) were associated with a reduced recanalization risk. Thus, we speculate that the LVIS stent has a stronger flow diverter effect than the Enterprise stent, which may be important for preventing recanalization in middle IAs.

Greater Hemodynamic Changes With Dense Coils may Relate to Lower Recanalization
-------------------------------------------------------------------------------

A lower PD and complete obliteration rate were identified as significant predictors of aneurysm recurrence ([@B16], [@B29]). A higher PD and complete obliteration rate are achieved by providing a sufficient coil mass, which results in thrombus formation at the aneurysm and progressive endothelialization at the neck to prevent aneurysm recurrence. In the present study, higher PD and complete obliteration rate were found in the LVIS group, which may relate to the denser mesh used in the LVIS stent (a denser mesh stent can stabilize small coils and provide a higher coil PD). Further, there was a significant difference in the hemodynamic alterations at aneurysms caused by coil placement between the LVIS and Enterprise groups. The relationship between coil PD and hemodynamics alterations was also previously reported ([@B30]--[@B32]), with hemodynamics in the aneurysm reduced by coil insertion, and reduced intra-aneurysmal velocity and WSS associated with a higher PD. Based on these findings, we suggest that the use of dense coils following the LVIS stent provides greater hemodynamic effects on the aneurysm dome, which may also contribute to the lower recanalization rate in the LVIS group. A further hemodynamic reduction in the aneurysm dome when using dense coils may contribute to the further reduction in the recanalization rate for LVIS SACE.

Large or giant aneurysms may exhibit more complex flow patterns caused by pulsatile flow than that for small aneurysms, and require stronger flow remodeling effects to promote thrombosis formation ([@B33]). Thus, the flow diverter may be the best choice. However, for medium-sized aneurysms, the higher density mesh of the LVIS stent compared with the Enterprise stent can increase the coil density in the aneurysm dome to further decrease hemodynamics. Moreover, the higher metal coverage of the LVIS stent produces a stronger flow diverter effect to reduce flow velocity at aneurysm neck. Thus, the combined hemodynamic actions of LVIS stents and dense coils may be important for preventing aneurysm recanalization.

Limitations {#s5}
===========

There are a number of limitations in the present study. First, the small sample size and mid-term follow-up may have influenced our findings, and a prospective study with a larger sample size should be performed for validation. Second, as for most CFD studies using vessel and aneurysm blood flow simulations, there are several assumptions (e.g., a rigid wall, laminar flow, general boundary conditions, and Newtonian blood) that may affect the hemodynamic results. Finally, the mechanisms of action of aneurysm occlusion cannot be explained by hemodynamics alone, with other factors having potential to influence outcomes, including thrombus formation, branching anatomy, branches arising from the aneurysm, the metal coverage of the stent, and luminal geometry changes.

Conclusion {#s6}
==========

In the LVIS group, the greater reduction in velocity at the neck plane might be caused by a higher metal coverage of LVIS stent, and the greater reduction in velocity and WSS at the aneurysm might be caused by a higher PD with LVIS stent. The greater hemodynamic alterations may be key factors associated with the lower recanalization in medium-sized aneurysms treated with LVIS SACE.
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